Trial NCT01937715

View at ClinicalTrials.gov 
Org. Study IDs: B2151007
Secondary IDs: 2013-002096-18

Last trial update was posted on 2016-08-18

MeSH Interventions

Bevacizumab Gedatolisib

MeSH Conditions

Colorectal Neoplasms

Other Conditions

Metastatic Colorectal Carcinoma

Stopping Reasons

B2151007 was prematurely discontinued due to Pfizer's change in prioritization for the portfolio and is not due to any safety concerns or regulatory interaction

Limitations And Caveats

As this study was terminated due to Pfizer portfolio prioritization prior to the Phase 2 portion, there are no efficacy evaluations for Phase 2.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID